AmBisome (Astellas Pharma US, Inc.)
Welcome to the PulseAid listing for the AmBisome drug offered from Astellas Pharma US, Inc.. This Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Astellas Pharma US, Inc. |
NON-PROPRIETARY NAME: | amphotericin B |
SUBSTANCE NAME: | AMPHOTERICIN B |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-08-11 |
END MARKETING DATE: | 0000-00-00 |
AmBisome HUMAN PRESCRIPTION DRUG Details:
Item Description | AmBisome from Astellas Pharma US, Inc. |
LABELER NAME: | Astellas Pharma US, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/12.5mL) |
START MARKETING DATE: | 1997-08-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0469-3051_3ab7fe3b-149e-4ff5-826a-1e23a6d39b55 |
PRODUCT NDC: | 0469-3051 |
APPLICATION NUMBER: | NDA050740 |
Other AMPHOTERICIN B Pharmaceutical Manufacturers / Labelers: